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INTRODUCTION
Streptolysin S,
interest,

a streptococcal toxin of current

consists of a polypeptide attached

ribonucleotide

(40)(4l).

to a poly¬

The active component of the

complex appears to be polypeptide,

and the polyribonu¬

cleotide functions as a carrier (20).

Possible Role of Streptolysin S in the Pathogene¬
sis of Rheumatic Fever:

Rheumatic fever is a non¬

suppurative sequel of streptococcal infections,
pathogenesis remains obscure.

but its

Auto-antibodies to heart

tissue have been demonstrated in this disease

(38)(28),

but whether they play a pathogenetic role remains
questionable.

Most auto-antibodies in other clinical

and experimental conditions appear to be innocuous and
some may even be protective

(46)(76).

The natural history of rheumatic fever, with its
multiple recurrences without shortening of the latent
period,

(51)

is unlike the experimental models of aller¬

gic diseases and could well be explained by a nonantigenic

toxin of group A streptococci.

oxygen-stable streptococcal hemolysin,
S.

Such is the

or streptolysin

A potent hemolytic and lysosome-disrupting agent

(82),

this toxin has some added features which further
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Increase its likelihood of being the agent of damage
in rheumatic fever:
dividing cells

(1),

(I)

it can be produced by non¬

such as one would expect to find

in the convalescent stage of streptococcal infections, ■
during the latent period of rheumatic fever;

and

(II)

its inhibitor, normally present in the serum of man
and other animals,
rheumatic fever
vation is

is decreased in patients with active

(60)(79).

Another intriguing obser¬

the mitosis-stimulating effect of streptoly¬

sin S on the peripheral lymphocytes of normal subjects
and of patients with diseases other than rheumatic
fever,

but not of patients with rheumatic fever (30).

It Is therefore believed that this study on the immunogenicity of streptolysin S may provide information
relevant to the pathogenesis of rheumatic fever.

If a

means were found to immunize experimental animals against
streptolysin S,
means to man,

it would be of interest to adapt such

and test the hypothesis that immunization

may prevent rheumatic fever.
At the outset It is important to note that strep¬
tolysin S is presently considered to be non-antigenic.
More specifically,
tolysin S

one may state that heretofore strep¬

(as It is prepared In the laboratory) has been

shown to be non-antigenic under certain well-defined
conditions

(to be discussed in the next subdivision).
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However,

a categorical statement cannot justifiably be

made as to the antigenicity of streptolysin S because
many alternative methods of demonstrating its anti¬
genicity or lack of antigenicity remain to be explored.
The possibility of making streptolysin S antigenic
by utilizing it as a hapten and coupling it to a protein
moiety which would serve as a carrier has not been tested.
Such an approach will be used in the present study.

Antigenicity of Streptococcal Hemolysins:

The study

of streptococcal hemolysins was greatly clarified by Todd
(78), who first clearly differentiated streptolysin S,
serum-soluble,

oxygen-stable hemolysin,

a

from streptolysin

0, which is readily formed in serum-free media and is
inactivated by oxygen.

It has been shown by him

and by many workers since,
powerful antigen,

(77),

that streptolysin 0 is a

and that infection with strains of

streptococcus which produce this hemolysin is generally
followed by a sharp rise in the antistreptolysin 0 con¬
tent of the serum.
In 1939,

Todd,

Cobum,

and Hill published a study of

antistreptolysin S and 0 titers in normal adults,
rheumatic children with,
streptococcal infections,
from similar infections,

non¬

or recovering from, hemolytic
rheumatic children suffering
but with no rheumatic activity,
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and rheumatic children in whom streptococcal infection
was followed by an acute attach of rheumatic fever.

The

variations in the antistreptolysin S titer were not
large.
data,

However,

from a statistical analysis of their

these authors concluded that in response to in¬

fection with hemolytic streptococci there is a rise in
the antistreptolysin S titer considerably above the nor¬
mal level

in the sera of all groups studied.

Those

rheumatic children who developed clinical signs of
rheumatic activity were the only exception^

In the sera

of these children the antistreptolysin S titer,
often above normal,

although

tended to remain relatively low.

Sera taken during the period of acute rheumatic fever
showed lower antistreptolysin S titers than sera taken
from the
activity.

same patients during periods of rheumatic in¬
Furthermore,

during rheumatic attacks the

antistreptolysin S titers tended to be lowest when the
clinical symptoms were most pronounced.

Todd e_fc al.

regarded the antistreptolysin S titer of human sera as
due to a specific antibody.

The fall in titer which

occurred during rheumatic activity they considered as
evidence of an abnormal antibody response
Humphrey

(33)

(79).

conducted a study on sera taken from

patients with streptococcal infections,

rheumatic fever,

and rheumatoid arthritis in various stages of their disease
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as well as in normal controls.

Nearly all sera taken

from sick persons had lower antistreptolysin S titers
than those from normal controls.

The highest anti¬

streptolysin S titers were found in normal adults and
in late convalescent cases of rheumatic fever.

In the

acute phases of streptococcal infections, rheumatic
fever, and rheumatoid arthritis and during the early
stages of convalescence,

the antistreptolysin S titers

were comparatively low.
Stollerman and 3emheimerfs study in 1950 (60)
confirmed the phenomenon of decreased antistreptolysin
S titers in the sera of patients with clinically active
acute rheumatic fever first noted by Todd e_t al.

(79).

It was also apparent that the fall in titer was not a
decrease in antibody, but more likely reflected a meta¬
bolic disturbance which resulted in a diminution of a
normal component of serum.

That the fall in antistrep¬

tolysin S is not specific for rheumatic fever was demon¬
strated by the finding of low titers in some cases of
diseases unrelated to streptococcal infection (60).

The

failure of any patient in this study to show'a rise in
the serum titer against streptolysin 3 following proved
streptococcal infection, or during the course of rheumatic
fever, when streptococcal antibodies had been demonstrated
at very high levels, is evidence that streptolysin

6
S is not antigenic in natural streptococcal infections
in man.

On the basis of these facts,

in conjunction

with the constancy and narrow range of antistreptolysin
S titer in normal human sera,
suggested

Stollerman and Bernheimer

that the inhibition of streptolysin S by human

serum is due to a normal component of serum rather than
to a specific antibody.

They also suggested that the

term "antistreptolysin S" be abandoned since this denotes
an antibody,

and they substituted the noncommittal expres¬

sion "streptolysin S inhibitor"

(SSI).

Todd reported that streptolysin 3 is not antigenic
when injected by itself.

Pour rabbits were injected sub¬

cutaneously and intravenously with approximately 36,000
50$ hemolytic units of streptolysin S in 16 doses,
eliciting an antistreptolysin S rise.

without

He, however,

ini¬

tially claimed that by prolonged courses of intravenous
injections of living group A streptococci into rabbits
it was possible to obtain antisera to streptolysin S.
(One rabbit developed an antistreptolysin S titer of 400
one week after a repeat I.V.
tococci;

injection with living strep¬

other rabbits similarly treated developed no

rises or smaller rises—to less than 100 units.

About

half the rabbits died during the course of the immuni¬
zation with generalized streptococcal infections)
(27).

(78)
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Humphrey

(33)

repeated these Immunization efforts

by giving rabbits intravenous injections of streptococci.
The first two injections consisted of hilled organisms,
but all later injections were of living streptococci.
Injections were given two or three times weekly,

with

rest periods of 20 days or more in between courses.

The

total volume of packed living organisms injected varied
from 0.6 to 1.0 ml.,
ml.

and of culture fluid from 12 to 20

A horse was also injected with five intramuscular

doses of formolized culture filtrate from streptococci
grown in yeast nucleic acid broth.

These five injections

were followed by a total of nearly three liters of untreat¬
ed filtrate,

in 26 doses over a period of 15 weeks.

No

evidence was obtained of an increase in antistreptolysin
S titer in either the rabbits or the horse.
Stolleraan, Bemheimer,

and McLeod

group of rabbits with one mgm.

(61)

injected one

of streptolysin S subcu¬

taneously twice weekly for two weeks followed by a rest
period of two weeks.

Twelve injections were given over a

period of three months.

A

second group

of rabbits was

injected intravenously twice weekly with 0.8 mgm.
streptolysin S per kg.

of

of body weight at each injection.

A total of nine injections was given.

A third group of

rabbits was injected twice weekly according to the schedule
outlined by Toad

(78), with increasing doses of whole

8
culture of living hemolytic streptococci grown in neopep¬
tone meat infusion broth, for 18 hours at 37°C.

Specific

antibodies to streptolysin S did not appear and no in¬
crease in inhibitory action was observed in these rabbits.
In 1965 Taranta and Bernheimer attempted immunization
of guinea pigs against streptolysin S toxoid

(74).

The

reason for using streptolysin S in a toxoid form was to
be able to give a very large dose of the toxin without
killing the experimental animal.
-total of 50 mgm.

In this experiment a

of streptolysin S was injected into each

of two guinea pigs with complete Freund * s adjuvant
mgm./ml.,

10,000 units/mgm.),

(20

corresponding to 500,000

hemolytic units before formolization and to 5,000 units
after formolization.
was detected.

ho neutralizing antibody response

Ouchterlony plates with the same strepto¬

lysin S preparation were negative for precipitating anti¬
bodies.
Thus,

all of the attempts described above to immunize

animals against streptolysin S were unsuccessful.

Toxicity of Streptolysin S:
(26),

and Barnard and Todd

(2)

Weld

(83),

(84), Hare

studied the toxic effect

of serum-extracted hemolysin (serum filtrates of living
streptococci possessing hemolytic activity)

in the mouse.

Toxic manifestations depended on the amount of hemolysin
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injected.

Following the injection of streptococcal ex¬

tracts containing 15-30 100% hemolytic units* of hemoly¬
sin,

death occurred in 24 hours;

death within an hour.
dyspnea,
lysis.

larger amounts caused

All of these animals showed

weakness, prostration,

and intravascular hemo¬

The animals which survived 90 minutes showed

hematuria and considerable enlargement of liver and spleen.
At autopsy no significant pathological lesions were ob¬
served.

in animals which survived longer

there was hematuria and,

(2-8 hours)

in the majority of animals,

marked degenerative changes in the tubular epithelium of
the kidney.

The glomeruli revealed no histological changes.

There was also marked necrosis of the lymphoid cells in
the follicles of the spleen and small focal necrosis in
the liver.

In animals surviving more than eight hours

there was almost always marked

jaundice,

inimals which

survived for one week showed very little pathologic change
in the liver,

but renal hemorrhages were found.

Rabbits

showed similar changes to those in mice although in smaller
degree.

Guinea pigs were more resistant to the effect of

hemolysin,

no intravascular hemolysis being observed.

*100% hemolytic unit—That amount of streptolysin S
which-will cause 100% hemolysis of a .7% suspension of
human red cells contained in 2 ml. of phosphate-buffered
saline, pH 7, in 30 minutes at 37°C.
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Both, the hemolytic and pathologic effects described
above could be prevented by heating the preparations to
50°C for 60 minutes.

Since the preparations of hemolysin

used in these studies were not purified,

it is impossible

to attribute with any degree of certainty the lesions
described

to streptolysin S specifically.

Other strepto¬

coccal products also present in the preparations include
streptokinase,

streptolysin 0,

and ribonuclease

(RUA-se)

all of which are susceptible to heating to 50°C for 60
minutes.

In view of the more recent findings on the

cytopathogenic effects of partially purified albuminhemolysin,

or REA-hemolysin on mammalian cells and the

effect of purified HITA-hemolysin on the basement membrane
of the kidney (including inhibition by anti-hemolytic
agents)

(70),

it may be assumed that at least part of the

pathological changes induced in the animals described
above was
Todd

caused by streptolysin S.
(78)

inoculated two rabbits subcutaneously with

serum-extracted hemolysin prepared in normal rabbit serum
from a group A strain.

Each rabbit received 24.5 cc.

of

hemolysin--average hemolytic titer approximately 200 100%
hemolytic units per cc.--in five doses spread over 12 days.
The rabbits were rested for 146 days before a second course
of subcutaneous injections was given consisting of 48 cc.
hemolysin in 11 doses spread over 25 days.

of

The first rabbit

died during this course while the second remained well.
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Two more rabbits were given three courses of serumextracted hemolysin,

the first two subcutaneously and the

third intravenously.

The rabbits remained in good con¬

dition during the period of inoculation and gained weight.
Subcutaneous inoculations were followed by local erythema
and thickening of the subcutaneous tissues at the site of
injection.

Intravenous inoculations did not cause any

symptoms and there was no evidence of hemoglobinuria.

This

may be due to the relatively low hemolytic titers of serum
extracted hemolysin.
Todd

(78)

attempted immunization of 23 rabbits with

living cultures of group A hemolytic streptococci.

In¬

jection of living cultures was usually preceded by I.V.
Inoculations of vaccine prepared by heating a broth cul¬
ture at 56°C for 30 minutes.

The animals were then rest¬

ed for seven days and immunization was begun by I.V.
Inoculation of 1.0 cc.

of supernatant fluid from a broth

culture which had been centrifuged for 20 minutes at 3000
r.p.m.

Nine of the rabbits died with hemolytic strepto¬

cocci in their blood,
ritis,

four were killed because of arth¬

and ten survived.

Stollerman at al.

(61)

injected six rabbits intra¬

venously with streptolysin S in a dose of 0.8 mgm. per
kg.

of body weight at each injection.

given twice weekly.

The toxin was

Nine injections were given to

three

V'
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of the animals while three died before the course of in¬
jections could be completed.
Ten rabbits were injected twice weekly,
the schedule outlined by Todd

according to

(78), with increasing doses

of whole culture of living organisms grown in neopeptone
meat infusion broth for 18 hours at 37°C.

Two animals

died during the first course of injections and one,which
developed

a large orbital abscess,

other rabbits lost weight,

was sacrificed.

appeared ill,

The

and in every in¬

stance a fall in serum titer of streptolysin S inhibitor
occurred,

ifter a period of rest,

the

seven surviving

rabbits were given a second course of injections similar
to the first.

The second course was tolerated well and

the animals did not sicken.

None exhibited an elevation

of inhibitor levels, but a reversion to the original nor¬
mal levels took place.
Bemheimer (7)
(10,000 units/mgm.)

injected 0.10 mgm.

streptolysin 3

intravenously into each of six mice.

One died in 3 hours,

one in 6-g- hours,

two between 32 and 48 hours,

one in 29 hours,

and one survived.

0.05 mgm.

of the same streptolysin S preparation was injected intra¬
venously into each of six rabbits.
and five survived.

Five rabbits were injected intracu-

taneously with 1 mgm.
above).

One died in 1 hour

streptolysin S

(same preparation as

Two of these animals died after the first injection
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while three survived.
18 injections

Two of the survivors received

(total of 180,000 units)

at the rate of

three per week while one received 15 injections
of 150,000 units)
Tan,

Hackel,

(total

also at the rate of three per week.
and Kaplan

(68)

observed necrosis of

renal tubular epithelial cells in mice harboring strep¬
tococci in intraperitoneal diffusion chambers.
Kaplan

Tan and

(69) found that this effect could be produced by

the injection of streptolysin S.
Snyder (59)

showed that preparations of the R11A-

hemolysin were pyrogenic in rabbits and that the pyrogenicity could be abolished by lecithin.

Non-antibody Nature of Serum Streptolysin S Inhibi¬
tor:

As early as 1949, in the investigation reported by

Humphrey

(33),

antistreptolysin 5 failed to conform to

the accepted definition of an antibody,

][.£. ,

a gamma¬

globulin which combines with an antigen and is produced
in response to the introduction of the antigen into the
tissues of the organism.

Antistreptolysin S was found to

occur in the sera of a wide variety of normal animal
species,

in the absence of evidence of either present

or past streptococcal infection;
immunization;

it did not increase on

and the antistreptolysin S activity was not

located in the gammaglobulin fraction in the sera of humans,

14

rabbits,

and horses.

The highest degree of streptolysin S inhibition
appears in the fractions associated with alpha-1 and
beta-1 lipoproteins when serum is fractionated by the
cold alcohol method.

When serum is fractionated by

salting out with ammonium sulfate,

the albumin fraction

is also associated with streptolysin S inhibition
Stollerman ejt al.

(61)

(61).

also found that serum phospho¬

lipids, particularly lecithin, play an important part
•in the inhibition,

either as components of lipoprotein

which may inhibit streptolysin 3,

or as stabilizing

agents for lipoprotein complexes,

or possibly in both

capacities.

A saline suspension of phospholipids, par¬

ticularly lecithin,

inhibits streptolysin S.

A marked

reduction of SSI occurs when serum is treated with
Cl. welchli lecithinase,
alcohol mixture.

or with ether or an ether-

Stollerman jet al.

concluded that SSI

in serum appears to be composed of a phospholipoprotein
complex and that the phospholipids of serum may play
a role in its stabilization as well as in its composition.

Relation of Streptolysin S jto Other Streptococcal
Hemolysins—Interchangeability of the Carriers of the
Hemolytic Moiety:

During the past 30 years several

oxygen-stable hemolysins have been reported to be

i'
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produced in cultures of growing streptococci or in suspen¬
sions of resting streptococci.

In 1934, Weld

(83)

showed

that a potent hemolysin indistinguishable from the hemo¬
lysin later described by Todd

(78),

could be obtained by

shaking washed streptococci with horse or human serum.
Todd

(78)

found that streptolysin S was produced only in

media containing whole serum.
al.

(31)(32)

Okamoto

(47)

and Hosoya et_

showed that yeast nucleic acid induced the

formation of a potent hemolysin in growing streptococcal
‘cultures.

Studies by Bemheimer

collaborators
(71)

(31)(32),

(4) (5), Hosoya and his

and Tanaka,

Hayashi,

and Maekawa

showed that the digestion of yeast RNA with pancreatic

ribonuclease markedly increased its hemolysin-inducing
capacity.
In 1956 Schwab showed that hemolytic material can be
obtained from streptococci subjected to sonic energy for
long periods of time

(53)(54).

named intracellular hemolysin.

The hemolytic material was
Schwab reported

(55)

the intracellular hemolysin is antigenic in rabbits,
thus may be different from streptolysin 3.

that
and

The nature of

this material and its possible relationship to the RITA or
serum hemolysin remains to be established.
In 1958 Ginsburg and Grossowicz

(16)

showed that

various strains of group A streptococci possess a cellbound hemolysin.

This hemolysin, which may be identical
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with that described by Weld

(83),

could not be released

from the cells by sonic disruption or by grinding with
glass beads

(16),

serum albumin,

but was released by treatment with

Tween-40,

-60,

-80,

or Triton X-205

(16).

The problem of the role played by such diverse ma¬
terials and substances as serum,

albumin,

detergents,

and

RUA in the induction of hemolytic activity from resting
streptococci was studied by Ginsburg and Harris

(20).

They proposed the concept of a carrier-hemolysin complex
on the basis of their studies.

Their experiments showed

transfer of hemolysin from one carrier to another,

in¬

activation of the respective hemolysins by proteolytic
degradation of the hemolytic moiety or by hydrolysis or
distortion of the carrier molecule,

inhibition of the

hemolytic activity of all the hemolysins by the same
inhibitors,

the lack of all these hemolysins in a single

streptococcal mutant,
hemolysins.

and the non-antigenicity of all these

These observations lead to the conclusion

that a single hemolytic group

synthesized by streptococci

can be bound by a variety of carriers which have affinity
for that active group.
This work also sheds new light on the cell-bound
hemolysin of streptococci

(83)(16),

and its relation to

the various forms of extracellular hemolysin described.
During the growth of the streptococci in media devoid of
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any of the carriers mentioned above,

the hemolysin is

synthesized and is found closely associated with the
bacterial cell.

Upon addition of a substance which has

greater affinity for this hemolysin than does the strep¬
tococcal cell-component involved,

the hemolysin is re¬

leased from the cells to form a complex with this sub¬
stance.

(20).

As to

the chemical nature of the carrier essential

for the induction or binding of hemolysin,
“families of compounds may be involved;
phospholipids,
third,

or fatty acids;

second,

first,

lipids,

RITA or RITA core;

substituted oxyethylene polymers,

and Tweens.

at least three

as Triton X-205

Ginsburg and Harris concluded that these

hemolysins represent a single hemolytic group synthe¬
sized by streptococci, which can be bound to a number of
carriers,

the original carrier being a component of the

streptococcal cell.

Possible Reasons for the Non-antigenicity of Strep¬
tolysin S:

Possible reasons for the non-antigenicity of

streptolysin S are its small size

(molecular weight, 12,000,

for the whole lysin or polypeptide-polyribonucleotide com¬
plex,

as determined by gel filtration)

looseness

(8)

and the

of the binding of the polypeptide to the poly¬

ribonucleotide as shown by the possibility of transfer of
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the hemolytic moiety from one carrier to another
According to Koyama

(4l)

(20).

the weight ratio of polypeptide

to polyribonucleotide of highly purified streptolysin S
is 0.3:1.

Therefore,

if streptolysin S

(polypeptide plus

polyribonucleotide) has a molecular weight of 12,000 the
molecular weight of the polypeptide,
is 2,800,

the active moiety,

and it should consist of approximately 28 amino

acid residues.

Antigenicity of Low Molecular Weirht Substances:
Antigenicity is usually hindered by low molecular weight.
However,

in recent years several examples of antibody pro¬

duction to low molecular weight substances

(even without

recourse to a carrier) have been reported in the litera¬
ture.

It is remarkable that Axelrod,

Trakatellis,

and

Hofmann have found that biologically inactive peptides
with a chain-length of 16 amino acids

(molecular weight

less than 2000)

Sela,

are immunogenic

(1).

Arnon showed synthetic polyamino acids,
weight around 4000,

Fuchs,

and

of molecular

to be immunogenic, provided that they

were of certain composition and contained certain amino
acid sequences

(56).

Antibodies have been produced

against synthetic oxytocin,
and Prout

(15).

an octapeptide,

by Gilliland

This evidence of antigenicity of low

molecular weight substances is in no way contradictory
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to the well-established observation that antigenicity
increases with increasing molecular weight.
low range

Even in the

of molecular weights the same rule applies:

Axelrod et. al.

found that immunogenicity of small pep¬

tides increases with increase in chain length.

In their

experience a peptide consisting of 20 amino acids was more
\
immunogenic than a peptide consisting of 16 amino acids

(1).
Methods to Make Antigenic Substances That are Not
Naturally

So:

At an increasing pace in recent years,

antibodies have been produced to substances which are not
naturally antigenic by a number of chemical and physico¬
chemical maneuvers.

Some of these maneuvers are relevant

to the problem at hand.
Historically, Landsteiner*s pioneer investigations
on the antigenicity of low molecular weight substances
are noteworthy.

His demonstration

molecule of low molecular weight,

(45)
e..£.,

that an organic
ascorbic acid,

functions as a hapten, when it is linked covalently to
a protein antigen as a carrier,

opened up a new avenue

for the study of antibody formation and structure.
Goodfriend, Levine,
bodies to

and Fasman

(23) produced anti¬

the low molecular weight polypeptides brady-

kinin and angiotensin.

They used water soluble caroo-
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diimides as coupling agents to produce hapten-protein
conjugates,

e_.s^.,

bradykinin-rabbit serum albumin

(ESA),

in which case bradykinin is the hapten and rabbit serum
albumin is the protein.
Butler, Beiser,
Beiser

(75)

and Erlanger

(9)

and Tannenbaum and

showed that purine and pyrimidine bases are

haptens when coupled to a protein such as bovine serum
albumin and that antibodies to the haptens react with
denatured PITA.

In addition Goebel and Avery

(22) had

demonstrated that pneumococcal polysaccharides, which
are non-antigenic in the rabbit by themselves,
as haptens when coupled to a protein.

Plescia,

could act
Braun,

and Palczuk were motivated by these observations to
further immunochemical studies or chemically defined
DNA-protein complexes.

They succeeded in producing anti¬

bodies to denatured PEA by utilizing a complex consisting
of denatured PEA and methylated bovine serum albumin (MBSA)
(48).

RATIONALE
It is known that streptolysin S consists of two dis¬
tinct portions, polypeptide and polyribonucleotide.

The
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polypeptide portion is an acidic polymer because it is
rich in glutamic acid and has a low content of basic
amino acids
al,

(41).

In light of the work of Plescia et

(48) with denatured DNA and methylated bovine serum

albumin

(MESA)

it seemed reasonable to try to make a com¬

plex of streptolysin S and MBSA,

a basic protein, which

presumably would interact electrostatically just like
denatured DNA and MBSA.
protein.

'The MESA would act as a carrier

In this way one might be able to make strepto¬

lysin S antigenic.,
On addition of MESA to streptolysin S a precipitate
formed and experiments were then conducted to determine
what happened to the streptolysin S hemolytic activity.
Was the hemolytic activity precipitated?
lytic activity remain in the supernatant?
lytic activity was precipitated,

Did any hemo¬
If the hemo¬

could it be recovered?

If the last possibility were the case one could infer
that the configuration of the

streptolysin S molecule was

maintained in an unaltered form in the precipitate.
An attempt was also made to produce antibodies to
RNA and RITA core according to the method
al.

(48).

of Plescia et,

Since RITA core is part of the polypeptide-

polyribonucleotide complex which goes under the name of
streptolysin S,

it was hoped

that such antibodies would

cross react with streptolysin S and inhibit it.

In this

regard it is noteworthy that streptolysin S is not com¬
mercially produced and its production is tedious and
time-consuming.

Most of the streptolysin S lots used

in these studies were prepared in Dr.
atory.

Taranta’s labor¬

RilA and RN.A core are both produced commercially,

and therefore,

are readily available.

Because of the success of Goodfriend e_t al.

in

production of antibodies to the low molecular weight
polypeptides bradykinin and angiotensin with the use
•of soluble carbodiimides as coupling agents

(23),

and

because streptolysin S is known to have a polypeptide
portion,

an attempt was made to produce antibodies to

streptolysin S by immunizing a rabbit with streptolysin
S coupled by l-ethyl-3-(3-dimethyl-aminopropyl)
diimide hydrochloride
bumin

(RSA).

("Ethyl CDI")

carbo-

to rabbit serum al¬

By analogy with GoodfriendTs work it was

assumed that the carbodiimide would act as a transient
carrier for M3S.4,

followed by replacement of the carbo¬

diimide by streptolysin S,

and formation of a peptide

bond between the latter and MBSA.
During the course of this investigation it was found
that streptolysin S when passed through a Seitz filter
was bound

to the filter and could be eluted from it by

solutions of high ionic strength.

Because of this chance

observation immunization attempts were made using a Seitz
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filter impregnated with streptolysin S.

The filter

served as a "carrier" for the streptolysin S as well as
an "adjuvant"

(irritant).

METHODS AND MATERIALS
Streptolysin S:

Streptolysin S was prepared by Worthing¬

ton Biochemical Corp.

and in Dr.

Taranta's laboratory

according to the method of Bemheimer
’tions suggested by Ginsburg

(19).

(5) with modifica-

The hemolysin was stored

in the lyophilized state and was dissolved in streptolysin
S buffer

just before use.

Streptolysin S Buffer:

Streptolysin S buffer was prepared

according to the method described by Bemheimer (5).
Stock Erythrocyte Suspension:

The stock erythrocyte sus¬

pension was prepared according to the method described by
Bemheimer (3).
Methylated Bovine Serum Albumin:

Methylated bovine serum

albumin was prepared according to the method of Sueoka and
Cheng

(63).

Adjuvant:

Complete Freund*s Bacto Adjuvant was obtained

from Difco Labs.
Measurement of Hemolytic Activity:

The hemolytic activity

was titrated according to the method of Bemheimer (3).
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One unit of streptolysin S is defined as that amount
of hemolysin which will cause 50^ hemolysis of a ,7%
suspension of human red blood cells contained in 2 ml.

of phosphate-buffered saline, pH 7, in 30 minutes at
37°0.
Standard Method for Titration of Serum Inhibitory
Activity Against Streptolysin S:

Serum inhibitory

activity against streptolysin 3 was determined accord¬

ing to the method of Stollerman and Bernheimer (60).
■Preparation of Ouchterlony Plates:

(as in the labora¬

tory of S. Halbert, and essentially as follows):

4.25

grams sodium chloride were dissolved in 500 ml. dis¬
tilled water.

2.5 grams Ionagar N:2 were added and the

suspension was boiled until all the agar was dissolved.

Solid sodium veronal, 4.13 grams, was then added, followed
by solid glycine,

7.5 grams.

After the last two ingred¬

ients were dissolved the solution was cooled to 60°C.
After 50 mgm. methiolate

(1:10,000) was added,

adjusted to 7.7 at 60°C with 5N HC1 or 5N NaOH.
shifted to 7.4 on cooling to 20°C.

the pH was
The pH

The agar was stored

in Erlenmeyer flasks and liquefied and poured into Petri
dishes when needed.

Holes were cut with a pattern cutter.

Modification of Farr Technique:

The Farr technique has

been published previously (12)(13).

The essential re¬

quirement for use of the Farr technique is that the
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antigen in question not be precipitated by saturated
ammonium sulfate.

Radioactive antigen which is custom¬

arily used in this technique has not been employed in
the present study.
streptolysin S,
of its own.

Instead,

the supposed antigen,

possesses a specific biologic activity

Its presence can be detected by hemolytic

titration.
i

Rabbits:

All rabbits used in this study were New Zealand

white male albinos, 7-8 pounds.
■Ribonuclease;

Ribonuclease was obtained from Worthington

Biochemical Corp.
Trypsin:
Corp.

(lot # R-547).

Trypsin was obtained from Worthington Biochemical

(lot § TR558SF).

Rabbit Serum Albumin;
from pentex,
Carbodlimide:

Incorp.

Rabbit serum albumin was obtained
(lot § 9).

l-ethyl-3-(3-dimethyl-aminopropyl)

diimide hydrochloride

carbo-

("Ethyl CDI") was obtained from the

Ott Chemical Co.
Ribonucleic Acid:

Ribonucleic acid

from Worthington Biochemical Corp.
Ribonucleic Acid Core:

Filter:

(lot # RNAC 632).

Millipore filters were obtained from

the Millipore Filter Corp.
047 00,

(lot # RNA 7DB).

Ribonucleic acid core was obtained

from Worthington Biochemical Corp.
Milllnore

(yeast) was obtained

Specifications were GSWP

GS 0.22u, white, plain,

47 mm.
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Seitz Filter:

Seitz filters were obtained from Republic

Seitz Filter Corp. Specifications were SI sterilizing #6
pore size 0.2u, diameter 60mm.

EXPERIMENTAL

i

Immunization with Streptolysin 3 and Methylated
Bovine Serum Albumin:

10 mgm. MBSA was dissolved in

.5

ml. distilled water in test tube #1 which was then placed
in an ice bath.

In test tube #2,

was dissolved in .5 ml.

4 mgm.

streptolysin S

streptolysin S buffer which had

been pre-ccoled in an ice bath.

The MBSA solution was

added to the streptolysin S solution followed by the im¬
mediate formation of a milhy white precipitate.

This

new suspension was titrated for hemolytic activity.

The

results of all titrations for injections in the SS-MBSA
immunization experiment are in Table I.
One ml.

of adjuvant was then added to the S3-MBSA

suspension and a smooth emulsion was prepared by thorough
mixing.

The next step was the injection of a rabbit with

this preparation.

All injections were intramuscular be¬

tween the scapulae.
totaled 2 ml.

(.5 ml.

Although the original solutions
streptolysin S in buffer plus

.5
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ml. MBSA in distilled water plus 1 ml.
mately 1.5 ml.

adjuvant)

approxi¬

remained after complete mixing with the

adjuvant.

Table !
Units of Streptolysin S
Rabbit

Injection
Number

Before Addition
of MBSA

After Addition
of MBSA

1

1

76,000

less than 80

1

2

90,000

less than 80

1

3

96,000

less than 80

1

4

108,800

3

1

42,000

290

3

2

105,000

550

3

3

125,000

750

3

4

108,800

4

1

105,000

550

4

2

125,000

750

4

3

240,000

3,600

4

4

108,800

not done

not done

not done

In an alternate method for the preparation of strep¬
tolysin S for immunization the heat lability of the toxin
was considered.

This lability is not due to oxidation,

and it is not due to surface inactivation.

Bernheimer

found that potassium ions protect streptolysin S against
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thermal inactivation (6)

thus decreasing its heat lability.

Because of this observation KC1 was utilized in some of
the immunization attempts.

The method was similar to that

detailed above except for the following points.

KC1 was

added to the streptolysin S solution before the MBSA
solution was added.

To the

150 mgm. KC1 was added.

.5 ml.

streptolysin S solution,

As can be seen in Table I,

more

hemolytic activity was preserved after the addition of
MBSA when KC1 was utilized
absence of KC1

(rabbits 3 and 4)

(rabbit 1).

than in the

After this new solution was

titrated for hemolytic activity the MBSA

solution was added

and the remainder of the procedure was completed

(as de¬

tailed above).
Rabbit 1 was given a series of three injections of
the SS-MBSA product.

Rabbit 2 was used as a control and

was injected with only MBSA.
in 1 ml.

distilled water.

10 mgm.

MBSA was dissolved

To this solution 1 ml.

vant was added and the two were mixed.

adju¬

Rabbits 3 and 4

were injected three times with streptolysin S to which
KC1 had been added plus MBSA.

All injections were given

at weekly intervals.
Each rabbit was bled before any injections had been
given.

from the date of the first injection the rabbits

were bled daily (4 ml.

each bleeding)

for three weeks

(until one week after the third injection had been given).
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Daily bleedings were performed because we were not only
interested in an antibody response but also in possible
changes in streptolysin S inhibitor (SSI) levels.

The

serum from each sample was separated and was frozen at
-4°C.

ifter all sera were collected for a given rabbit,

the anti-hemolytic activity of the pre- and post-injection
sera was determined.
The results of the anti-hemolytic activity determi¬
nations are presented in figure 1.

It is clear from this

.data that there was no significant change in the antihemolytic activity of the post-injection sera when com¬
pared with the pre-injection serum.
With the above approach only those antibodies directed
against the hemolytic site may be presumed to be detected.
It is possible to hypothesize antibodies against other
parts of the molecule which under the conditions of this
system would go undetected since no precipitate is formed.
Because of this possibility,

other approaches were utilized

in an effort to detect the presence of antibodies against
streptolysin S.
The plate method of Ouchterlony gave the following
results

(Figure 2).

sentative
bits 1,

3,

The plate illustrated below is repre¬

of all plates for post-injection sera from rab¬
and 4.

/

INHIBITOR (units/ml.
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FIGURE 2—Ouchterlony plate showing the reactivity
of serum (21 days after injection 4) from rabbit 4
injected with streptolysin S-MBSA complex:
1.
streptolysin S, 10 mgm./ml.; 2. EE A core, 10
mgm./ml.; 3. RKA-se, 0.01 mgm./ml.; 4. EE A, 10
mgm./ml.; 5. MBSA, 10 mgm./ml.; 6. MESA, 1 mgm./ml.;
7. Serum.

Precipitates formed between the center well
wells 1,

2,

(7)

and

and 3 with a reaction of identity between them.

Since RNA-se is used in the preparation of EE A core and
REA core in the preparation of streptolysin S,

the con¬

clusion appears justified that the antibody here detected
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Is directed against RKA-se just as in the immunization
experiments with RNA core to be described later.
this system,

Using

no antibodies were detected in post-injection

sera from rabbit 2.

ho precipitating antibodies directed

against MBSA were present in any of the post-injection
sera (rabbits 1 through 4).
To detect the possible presence of non-inhibiting
and non-precipitating antibodies,

a third method was used,

a modification of the Parr technique

(12) (13).

With this

method one may be able to precipitate such antibodies
bound to streptolysin S.

The protocol presented below

was arrived at after several preliminary experiments.
This experiment was performed with representative sera
taken from rabbits 1,

3,

and 4.

Tubes 1 through 6* were

prepared as indicated in Table II.
After thorough mixing,

tubes 1 through 6 were incu¬

bated at 4°C for 24 hours while tubes 1*
incubated at 37°C for 30 minutes.

After incubation both

sets of tubes were treated similarly.
ammonium sulfate solution was added
5 and 1T,

3',

and 5f.

2 ml.

4,

saturated

to tubes 1,

At the same time 2 ml.

S buffer was added to tubes 2,
6*.

through 6' were

and

streptolysin

and 6 and 2',

All of these tubes were mixed,

3,

4’,

and

incubated at 4°C for

30 minutes and then centrifuged at 1500 rpm for ten
minutes.

The supernatants were then titrated for hemolytic
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activity.
presented

The results of a typical experiment are
in Table III

(on page 34).

Table II

Tube

-

Streotolysin S
600 units/ml.

ITormal
Serum*

Postinjection
Serum*

Streotolysin S
Buffer

1

1 ml.

1 ml.

—

—

1*

1 ml.

1 ml.

—

—

2

1 ml.

1 ml.

—

—

2*

1 ml.

1 ml.

—

—

3

1 ml.

—

—

1 ml.

3*

1 ml.

—

—

1 ml.

4

1 ml.

—

—

1 ml.

41

1 ml.

—

—

1 ml.

5

1 ml.

—

1 ml.

—

5*

1 ml.

—

1 ml.

—

6

1 ml.

—

1 ml.

—

6*

1 ml»

1 ml.

,, „_

* Inactivated
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Table III

Part A— Incubated at 4°C for 24 hours.

Tube

1

2

3
4
5
6

Contents

llormal
serum
normal
serum
Streptolysin
S buffer
Streptolysin
S buffer
Post-injection
serum*
Post-injection
serum

Original Units
of Streptolysin
S

Final Units
of Streptol.ysin S

Percent
Recovery

600

210

35 %

600

320

53%

600

385

64%

600

490

82%

600

320

53^

600

350

58%

Part B—Incubated at 37°C for 30 minutes.

Tube

*

1

'

2

3*
4*
5'
*

6

Contents

Normal
serum
Normal
serum
Streptolysin
S buffer
Streptolysin
S buffer
Post-injection
serum
Post-injection
serum

* Rabbit 4,

Original Units
of Streptolysin
S

Final Units
of Streptolysin 3

Percent
Recovery

600

240

40%

600

280

47%

600

190

32 %

600

255

42%

230

58%

330

55%

600
600

21 days after injection 4.
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The basic point to be noted is that there was no
decrease in recovery of hemolytic activity in the immune
serum-with respect to recovery in the normal serum.
Although normal serum and immune serum with saturated
ammonium sulfate solution yielded a lower recovery of
hemolytic

activity than did comparable tubes without

ammonium sulfate,

the same phenomenon was observed

in the

control tubes which contained streptolysin S buffer in
place of serum

(tubes 3 and

3').

Therefore,

this decrease

in hemolytic activity cannot be explained on the basis of
precipitation of complexes consisting of serum constitu¬
ents

(antibody or otherwise) and streptolysin S by

ammonium sulfate solution.

Precipitation of Streptolysin S by; Methylated Bovine
Serum Albumin and Its Recovery from the Precipitate:
Because of the absence of an antibody response in the
previous experiment,

the question arose whether strepto¬

lysin S was destroyed in the preparation of the 3S-MBSA
complex.

This possibility was explored by the following

experiment.
10 mgm. MBSA was dissolved in 0.5 ml.
water and 4 mgm.

streptolysin S

distilled

(19,600 units/mgm.,

78,400

36
units total) was dissolved in 0.5 ml.
buffer.

streptolysin S

The solutions were prepared in an ice bath and

on mixing the two a precipitate formed immediately.

The

suspension was centrifuged and the precipitate washed
twice with 4 ml.

streptolysin S buffer (diluted 1:2 with

distilled water).

The hemolytic activity of the super¬

natant and the washings was less than 20 units.
The precipitate was resuspended in 1.5 ml.

strepto¬

lysin S buffer and divided into three equal parts

(Table

IV).
Table IV
Tube

Resusoended Pot.

Additional Contents

1

.5

ml.

2 ml.

2

.5

ml.

2

3

.5

ml.

2 ml. phosphate buffer, pH 9.5

streptolysin S buffer

ml. rabbit serum

(unheated)

Controls
Tube

Streptolysin S
Buffer

Additional Contents

4

.5

ml.

2 ml.

5-

.5

ml.

2

6

.5

ml.

2 ml. phosphate buffer, pH 9.5

ml.

streptolysin S buffer
rabbit serum (unheated)

All suspensions were incubated for one hour at 37°C
and were then centrifuged.

Hemolytic activity of the

supernatants was assayed with red blood cells from the
rabbit which had provided the serum

(to avoid immune
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hemolysis).
The hemolytic activity of tubes 1 through 6 is pre¬
sented in Table V.

Table V

Tube

Hemolytic Activity

(units/ml.)

less than 20*

1
2

137

3

6,850**

4

0

5

0

6

0

* Ho hemolysis at 1:20 dilution.
** 6,850

(hemolytic units/ml.) x 2.5

(number of test tubes)

(ml./test tube)

- 51,375 units.

Thus,

x 3

65/5 of

the initial activity can be recovered with the
extraction procedure used for tube 3.

The finding that streptolysin S hemolytic activity
could be recovered in such high yield from the precipi¬
tate which formed when streptolysin S and MESA were mixed
is direct evidence that the bulk of streptolysin 3 was
not destroyed in the preparation of the SS-MBSA complex.
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Determination of Optimal Ratio of Ribonucleic Acid,
Ribonucleic Acid Core,

and Streptolysin S to_ Methylated

Bovine Serum Albumin for Immunization Procedures:
following experiments were performed
the ratio

The

to establish whether

of streptolysin S to MBSA utilized in the SS-MBSA

immunization experiment was an ideal one,

i .e.., whether the

complex prepared was as rich as possible in streptolysin S.
Since streptolysin S was available in very limited amounts
immunization efforts with complexes consisting of MBSA with
RITA and RNA core respectively were also planned.

Therefore,

additional experiments were performed to determine optimal
ratios of RITA and RITA core to MBSA for immunization.
Varying amounts of R1IA dissolved in .5 ml.

streptolysin

S buffer were added to each of seven test tubes as indicated
in Table VI.

On the addition of a constant amount of MBSA

to each tube a precipitate formed immediately.

The new

suspension was incubated in an ice bath for ten minutes.
Then the tubes were centrifuged,

and the optical density of

the supernatants at 260 mjji and 280 m^ was determined
(Table VI).

The object of this procedure was to find the

minimum amount of RITA necessary to combine with all of the
MBSA

(said another way,

to find the largest amount of RITA

which could be completely precipitated by .5 mgm.
By determining the O.D.

MBSA).

of the supernatants at 260 mjji and

280 mjj any MBSA or RITA remaining in the supernatants after

FIGURE 3 - Optical density at 260 ip and 280 mpi of super
natants of RHA - MESA precipitates.
The amount of MB3A was
lcept constant (.5 mgm. ).
The amount of REA varied and is
indicated on the abscissa: optical density at 260 mu,°
o;
optical density at 200 mp, Q—®.
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hemolytic activity

(Table VIII).

Table VII
Tube

Mem. RITA core
in .2 ml . SS
buffer

Mem. MBS A in
,2 ml., distilled
water

0.D. at
260 mjJ.

0.D. at
280 mu

A

1.25

.5

52.4

24.0

B

.94

.5

36.4

16.6

C

.625

.5

21.6

9.8

D

.31

.5

7.3

3.2

S

.16

.5

3.4

1.8

P

.08

.5

2.5

1.7

G

.04

.5

3.3

2.1

Table VIII
Tube

Units of SS
in .2 ml.
SS buffer

Mgm.

SS

Mem. MBSA
in .2 ml.
distilled
water

Recovery
of SS in
units

O.D.
at
25b
mu

O.D.
at
mu

2^0

A

20,000

1.25

.5

8,000

29.2

14.8

B

15,000

.94

.5

4,500

21.6

11.0

G

10,000

.6 25

.5

180

10.5

5.2

D

5,000

.31

.5

8

3.4

2.0

E

2,500

.16

.5

9.2

2.3

1.5

P

1,250

.08

.5

33.2

2.2

1.7

G

625

.04

.5

36

2.4

2.0

The object was to determine the minimum amount of streptolysin

1——

; ji t:!:::
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AMOUNT OS' SNA : 00RE ' (ingra.)
FIGURE 4- - Optical density at 260 mp and 280 mp of super¬
natants of RNA core - MB3A precipitates.
The amount of MB3A
was kept constant (.5 mgra.).
The amount of RNA core varied
and is indicated on the abscissa: optical density at 260 mfJ,
o~ ° ; optical density at 280 mp. ®
©.
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S necessary to combine with all of the MBSA (said another
way, to find the largest amount of streptolysin S which
could be precipitated by .5 mgm. MESA).
Figure 5,

As seen in

the low point with respect to hemolytic activity

present in the supernatants falls at .31 mgm.
S (tube D).

streptolysin

On the basis of this experiment the optimal

ratio of streptolysin S to MESA was calculated to be .3
mgm. streptolysin 3 to .5 mgm. MESA or .6 : 1.0.
The optimal ratio of streptolysin S to MESA (also RITA
‘and RiTA core to MESA) arrived at in this experiment (.6 to
1.0) is similar enough to the ratio employed in the SS-MBSA
immunization experiment (.4 to 1.0) to
ratio used was an adequate one.

conclude that the

On the basis of these

results the immunization efforts with RNA and RITA core will
utilize the ratio .6 to 1.0 (REA:MBSA and RNA coreiMBSA).

Immunization with Ribonucleic Acid:

QO mgm. MESA

was dissolved in .75 ml. distilled water and 50 mgm. RITA
was dissolved in .75 ml. streptolysin S buffer, both at
room temperature.

After the MESA solution was added to

the RUA solution a milky white precipitate formed immedi¬
ately.

The new product (1.5 ml.) was mixed with 1.5 ml.

complete Freund *s adjuvant.

The emulsion was injected

♦

i

r*

♦

90

80

70

60

50

40

50

20

10

FIGURE 5 - Optical density at 260 mp and 280 mp and hemolytic
activity of supernatants of streptolysin S - MBSA precipitates.
The amount of MBSA was kept constant (.5 mgm.).
The amount
of streptolysin S varied and is indicated on the abscissa:
optical density at 260 mp,o-o ; optical density at 230 mp,®
hemolytic units,o—□.

_
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into each of two rabbits

(333,

injections were subcutaneous)
of neck;

.5 ml.

334)
,5 nl.

as follows:

in bach and front

in each of four foot pads.

were bled pre- and post-injection

(all

(day 0,

Both rabbits
8, 16,

26,

34,

37, 48).
All sera were tested for their titer of inhibitory
activity against streptolysin S by the standard method.
The results presented in Figure 6 show only minor variations
in inhibitory titer which are not suggestive of an antibody
.response.
All sera were tested on Ouchterlony plates as illus¬
trated in Figure 7.

Under these conditions the post¬

injection sera from rabbit 333 showed no antibody response.
Pre-injection serum from rabbit 334 showed a line of pre¬
cipitation with RITA core.

On the eighth post-injection

day the line of precipitation between serum and RITA core
took longer to appear.

On the ninth post-injection day a

line appeared between the serum and the RITA which by day
16 had become more evident than the RITA core line.

Finally

by day 34 a suggestion of a double precipitating system
appeared against RITA and RRA core
identity in each of the lines).

(with a reaction of
This would indicate the

presence of antibodies against two distinct constituents
of both RITA and RITA core.

INHIBITOR (units/ml.

complexes

(333 and 33^)

in complete Freund's adjuvant.
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FIGURE.?*—Ouchterlony plate showing the reactivity
of serum (post-injection day 34) from rabbits 333 and
334, both injected with RNA-MBSA complex:
1. serum,
rabbit 333; 2. R21A core, 10 mgm./ml. ; 3. RITA core,
10 mgm./ml.; 4. serum, rabbit 334; 5. RRA-se .01 mgm./
ml.; 6. RRi-se, .01 mgm./ml.; 7. RITA, 10 mgm./ml.
The first two rabbits immunized with RHA died a few
months post-injection.

Four more rabbits were immunized

exactly as described above.

The sera were tested for their

titer of inhibitory activity against streptolysin S by the
standard method.
body response.

The results are not suggestive of an anti¬
Ouchterlony plates showed no evidence of

an antibody response against EIA,
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Immunization with. Ribonucleic Acid Core:

The details

of this procedure were the same as those in the immuni¬
zation with ribonucleic acid except for the substitution
of RNA core for RITA

(rabbits 81 and 82).

All sera were tested for their inhibitory titer
against streptolysin S by the standard method.

The results

presented in Figure 6 show only minor variations in the
inhibitory titer which are not suggestive of an antibody
response.
All sera were tested on Ouchterlony plates as illus¬
trated in Figure 8.

Under these conditions both rabbits

showed a line of precipitation between serum and RNA core
and serum and RNA-se which was present on the twenty-sixth
post-injection day in rabbit 81 and on the sixteenth post¬
injection day in rabbit 82.

These lines for both rabbits

showed a reaction of identity.

Thus,

the antibody formed

was against a constituent present in both RITA core and
RNA-se.

The most likely possibility is that the antibody

was against RNA-se which is used in the preparation of
RITA core and,

therefore,

is a likely contaminant.

The two rabbits immunized with RNA core

(81 and 82)

were re-injected with an RNA core - MESA complex six months
after the initial set of injections and an additional two
rabbits were given their first set of injections.

The

rabbits were bled at three and four weeks post-injection

#
<
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and all sera were tested for their inhibitory titer
against streptolysin S by the standard method.

The

results are not suggestive of an antibody response.

FIGURE 8--Cuchterlonyvplate showing the reactivity
of serum (post-injection day 26) from rabbit 81
and of serum (post-injection day 16) from rabbit
82, both injected with REA cere - MESA complex:
1. serum, rabbit 81; 2. REA core, 10 mgm./ml.;
3. REA core, 10 mgm./ml.; 4. serum, rabbit 82;
5. REA-se, 0-.1 mgm./ml.; 6. REA-se, 0.1 mgm./ml.;
7. REA, 10 mgm./ml.

All sera were tested on Ouchterlony plates and
showed lines of precipitation with RNA core and RNA-se
(Figure 9).
As

These lines gave a reaction of identity,

stated previously the most likely possibility is

that the antibody was against RNA-se.

FIGURE 9—Ouchterlony plate showing the reactivity
of serum (three and four weeks post-injection) from
rabbit 82, injected with RHA core - MBSA complex:
1. post-injection serum, day 21; 2. RITi-se, 0.1
mgm./ml.; 3. RNA-se, 0.1 mgm./ml. ; 4. post-injection
serum, day 28; 5. RNA, 10 mgm./ml.; 6. RITA, 10
mgm./ml.; 7. RNA core, 10 mgm./ml.
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Immunization with Streptolysin S and Rabbit 3erum
Albumin Coupled by a Carbodiimide;

10 mgm. rabbit serum

albumin (RSA) and 10 mgm. streptolysin 3 were dissolved
in 0.5 ml. distilled water in an ice bath.
solution .25 ml. water containing 200 mgm.
added.

To this
ethyl CDI was

The reaction between ethyl GDI and the streptoly¬

sin S - RSA mixture was allowed to tahe place at room
temperature with gentle agitation for 50 minutes.

The

reaction was terminated by dialysis against distilled
water for 24 hours in the cold.

Indirect evidence of

successful conjugation was the formation of a precipitate
within 24 hours.

Both the precipitate and the soluble

material were suspended in an equal amount of Freund*s
adjuvant and the resulting emulsion was used for immuni¬
zation.
A single rabbit was injected intramuscularly and
subcutaneously twice, 51 days apart.

The rabbit was

bled before the first injection and on post-injection days
21, 51, and 50.

In an effort to demonstrate antibodies

directed against the hemolytic site of streptolysin S,
the anti-hemolytic activity of the pre- and post-injection
sera was determined.

There was no detectable increase in

the anti-hemolytic activity of the post-injection sera
when compared with the pre-injection serum.
?

A second attempt to detect antibodies to streptolysin S
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utilized gel diffusion on Ouchterlony plates.

With this

method one could identify any precipitating antibody to
streptolysin S whether or not the antibody was directed
against the hemolytic portion of the molecule.

The

results of the gel diffusion test are presented in figures
10 and 11.

1

FIGURE 10—ouchterlony plate (I) showing the
react*vity_of serum from a rabbit injected with
s S “

7 ?Si.?ocPlsx: I- pre-injection

d'afso-0? SstrrmUdW ?ls 4. post-injection L™,

B^emic^hoo^?

S’

5

'^thinghn
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FIGURE 11-—Ouchterlcny plate (II) showing the
reactivity of serum from a rabbit injected with
streptolysin S - RSI complex: 1. pre-injection
serum; 2. post-injection serum, day 21; 3. post¬
injection serum, day 31; 4. post-injection serum,
day 50; 5* streptolysin S, 5 mgm./ml.> Or.
laranta’s laboratory.
There were two bands of precipitation on Flate I between
the central well (5) and well 4.

Plate II had one band

of precipitation between the central well (5) and well
4.

There were no other lines of precipitation on either

plate.

Thus, antibodies were present in serum from post¬

injection day’50 against two distinct antigens present in
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the Worthington Biochemical Corp. streptolysin S
preparation.

This same serum contained antibodies

against one antigen present in the streptolysin 3 pre¬
pared in Dr. Taranta’s laboratory.

To find out whether

one of these antigens was streptolysin S itself, the
following experiment was carried out.
Streptolysin S was added to pre- and post-injection
sera in an amount sufficient to form a visible precipi¬
tate in the latter.

After incubation in the cold over-

night; the precipitates were centrifuged out and the
supernatants were titrated for hemolytic activity.

There

was no decrease of hemolytic activity in the supernatant
of the post-injection serum as compared to that of the
pre-injection serum.

Therefore, it was concluded that the

antibodies present in the post-injection serum were not
against streptolysin 3 itself, but rather against impuri¬
ties present in the streptolysin 3 preparations used.
(By analogy with the results obtained on immunization
with the streptolysin S-MBSA complex and with the RITA
core-MBSA complex, one may surmise that one of the anti¬
bodies detected in the present experiment was directed
against ribonuclease.)
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Seitz Filtration of Streptolysin S and Extraction
of Streptolysin S Hemolytic Activity by Hirh Ionic
Strength Solutions:

35 ml. non-dialyzed streptolysin

S was passed through a Seitz filter in 5 ml. aliquots.
This was followed by 30 5 ml. washings with the medium
used for the preparation of streptolysin S less maltose,
cysteine and ENA core.

Finally eight 5 ml. aliquots of

each of the following solutions were passed through the
filter successively:

medium described above plus .5%

NaCl, 1% Nad, 2% Nad, k% Nad, 8% Nad, 16% Nad and
a saturated solution of Nad respectively.

Each 5 ml.

aliquot was collected separately and titrated for hemo¬
lytic activity.

Then the optical density was determined

at 260 mju and 280 m/i.

The results of a typical experiment

are presented in Figure 12.
The total amount of hemolytic activity passed through
the Seitz filter was 224,000 units.
eluates was 126,500 units or 56^.

The recovery in the
The recovery of 260 mu

absorbing material was 93/£ and the recovery of 280 mju
absorbing material was 54^.

Immunization with Streptolysin S Bound to a Seitz
Filter:

A Seitz filter with streptolysin S bound to it

was implanted intraperitoneally in a series of eight

UNITS
HEMOLYTIC

260 mjM ,
11:1

0 •

-’o ; optical density at 280 m/u,®-« ; hemolytic units,
f'be 1 is unfiltered streptolysin S.
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rabbits.

A control rabbit was implanted with only a filter

free of streptolysin S.
presented below.

The details of the procedure are

See Table IX for the number of units of

streptolysin S bound to each filter.

Table IX
Rabbit

Units of Streutolys in S Imulanted

327

292,000

328

190,000

329

142,000

330

147,000

331*

146,000
63,000

332*

146,000

335

132,000

342

Control

343

145,600

(intraperitoneal)
(subcutaneous)

The following procedure was conducted under sterile
conditions

(except for rabbits 331 and 332).

Tor each

rabbit an average of 30 ml. non-dialyzed streptolysin S
was passed through a sterile Millipore filter to rid the
streptolysin S preparation of any streptococci still pre-

Preparation of the Seitz filter for these rabbits
was not performed under sterile conditions.
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sent.

The streptolysin S was then passed, through a

sterile Seitz filter in 5 ml.

aliquots.

.All solutions

used for washing were first passed through a sterile
Millipore filter.

After the streptolysin 3,

30 5 ml.

washings with the medium described in the previous section
were passed through the Seitz filter followed by eight
5 ml.

aliquots of the same medium with .3% had added

and eight with 1% NaCl added.

All solutions passed through

the filter were kept in an ice bath before use.

All fil¬

trates were disposed of.
Under sterile conditions the filter was mashed with
a mortar and pestle in 20 ml.

chilled streptolysin S

buffer and implanted intraperitoneally in a rabbit.

All

rabbits were bled pre- and post-implantation and were given
prophylactic antibiotics post-operatively.
The results of these attempts at immunization are
presented

in figures 13 and 14.

After implantation

streptolysin 3 inhibitor levels rose in rabbits 330,
and 332

(Table X).

There was a transient opalescence

in the post-implantation sera from rabbits 328,
331 and 332

331

329,

330,

(Figure 13).

If one compares SSI levels and opalescence data for
individual sera as presented in Figure 13,
that

(1)

it is evident

opalescence occurred in sera from rabbits 328

and 329 without a concomitant rise in SSI,

(2)

opalescence
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occurred
tant rise

in sera from rabbits 331 and 332 with a concomi¬
in SSI and

(3)

a rise in SSI occurred in serum

from rabbit 330 without the simultaneous occurrence of
opalescence.

Table

Rabbit

X

Streptolysin S Inhibitor (units/ml.)
Pre-implantation
Peah VaXue
Post-imolantation

Percent
Increase

33

165%

10

666

6500%

10

33

250%

330

12.5

331
332

On Ouchterlony plates all anti-sera showed no reaction
with R11A core or RHA-se.

Most early post-implantation sera

reacted with non-dialyzed streptolysin 5
pre-implantation serum (rabbit 34-3)

(Pigure 15).

One

and several post¬

implantation sera from the control rabbit also reacted with
the non-dialyzed streptolysin S.

Since this precipitation

reaction occurred so soon after the implantation it could
not be due to an antibody but could perhaps be due to an
acute phase reactant.
There were three rabbits who died on whom a bleeding
was performed on the day preceding death
329 and 332).

(rabbits 328,

The sera from two of these three bleedings

clotted after the initial clot had been removed

(rabbits

INHIBITOR (units/ml.)

FIGURE 13- Serum Inhibitor is shown in bar form; opalescence, 0 - 4+,
and precipitation on Ouchterlony plate of serum against streptolysin S,
0 /+. are shown above.
_
_

INHIBITOR (units/ml.)

DAY POST-IMPLANTATION
FIGURE 13- Continued,

0

1

2

3

FIGURE 13- Continued,

4

5
6
7
8
DAY POST-rHPLMTATICW

9

10

INHIBITOR (units/ial.)

TOTAL LIPIDS (mgms. #), TOTAL CHOLESTEROL (mgms. $),

c

FIGURE l't- Continued.
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328 and 329).

The significance of this finding is not

known.

-p OJ

FIGURE 15—Cuchterlony plate showing the reactivi
of serum.(post-implantation day 2) from rabbits 3
and 330, bo.th implanted with streptolysin S bound to
a Seitz filter:
1. serum, rabbit 328; 2. RRA-se,
0.1 mgm./ml.; 3. RITA-se, 0.1 mgm./ml.; 4. serum,
rabbit 330; 5. RITA core, 10 mgm./ml.; 6. R1L4 core,
10 mgm./ml.; 7. strepoolysin 3,

The following biochemical changes took place in the
control rabbit

(342) and in a rabbit implanted with strep¬

tolysin 3 bound to a Seitz filter

(343)

Table XI.

The
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post-operative observation period,

which, was limited

by the survival of the animal, was five weeks for rabbit
342 and four weeks for rabbit 343.
cholesterol,

cholesterol esters,

Total lipids,

total

and BU1T went up while

potassium stayed the same after the operative procedure.
Total lipids returned to the pre-implantation level within
five weeks for rabbit 342 and two weeks for rabbit 343.
Total cholesterol returned to the pre-implantation level
within five weeks for rabbit 342 and did not return to
‘the pre-implantation level during the observation period
for rabbit 343.

Cholesterol esters and BUN returned to

the pre-implantation level within three weeks for rabbit
342 and two weeks for rabbit 343.

It is evident from

Figure 14 that the transient but marked hyperlipemia
observed post-implantation in one experimental
one control animal
studied),

(342)

(343)

and

(the only two animals thus

occurred primarily in the non-cholesterol portion

of the serum lipids.
The antistreptolysin 0

(130)

titer was determined

for all sera in the above experiment.
sera were

When post-implantation

compared with pre-implantation sera,

in the 130 titer was observed.

Therefore,

no elevation

the lipid

alterations that occurred were not such as to provoke
inhibition of streptolysin 0 although it is known that
some lipoprotein alterations may cause an inhibition of

68
streptolysin 0.
Table XI

Rabbit

(mgms. %)
pear value
Post-implantation

percent
Increase

342

260

750

190^

343

120

590

390$

Rabbit

'

Total Lirids
Pre-implantation

Total Cholesterol (mgms. %)
Pre-imnlantation
Peak Value
Post-implantation

Percent
increase

342

70

150

115$

343

45

115

155$

Rabbit

Cholesterol Esters (mgms. %)
Pre-implantation
Peak Value
Post-implantation

Percent
Increase

342

58

94

62$

343

36

85

136$

Rabbit

BUN (m§ ms.
Pre-implantation
Peak Value
Post-implantation

Percent
Increase

342

12

26

115$

343

21

73

250^

In the three rabbits which were followed for two
weeks or more

(330, 335 and 343), the absence of an A50

response argues against a streptococcal infection and
also argues against the presence of streptolysin 0 in
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the streptolysin S preparations that were injected,
bound to a Seitz filter,

into each rabbit.

DISCUSSION

The present data suggest that streptolysin S when
injected into rabbits as a complex with MBSA is not anti¬
genic.

A precipitating antibody was obtained,

but gel

diffusion on Ouchterlony plates demonstrated that it was
directed against RMi-se.

However,

conclusions on the lack

of antigenicity of streptolysin S under these experimental
conditions must be tempered by the knowledge that the
immunization efforts were not as vigorous as they might
have been because of the difficulty of obtaining strepto¬
lysin S in large amounts.
It is quite possible that immunization over a period
of months might have been successful where our three-week
schedule

(one set of injections per week) failed.

The

formation of antibodies to poorly immunogenic molecules
can be slow.

Satisfactory levels of antibody against

ACTH were found only after four to five months of
immunization

(14).

The immunization of a large number of

animals would also have been helpful,

as animals may show

.
«
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marked individual variations in response to a given
antigen.

Therefore,

if one were able to obtain strep¬

tolysin S on a commercial basis it would seem worthwhile
to pursue further the antigenicity of a streptolysin
S - MESA complex.
Other problems inherent in the immunisation pro¬
cedure may also exist.
lytic

Although streptolysin S hemo¬

activity could be recovered in good yield from

the precipitate which formed on the addition of MESA
to streptolysin 3,

the streptolysin S - MESA complex

may deteriorate very shortly after injection into a
rabbit.

This may even occur before the complex has had

an opportunity to enter and stimulate appropriate antibody-producing cells.

Conversely,

may remain buried in the complex,
antibody forming cells,

the streptolysin 3
unavailable to the

although it was shown that rabbit

serum can extract small amounts of it from the complex.
Moreover,

the heat-lability of streptolysin S may render

it incompetent as an antigenic determinant due to heat
inactivation after injection even when coupled to a
carrier such as MESA.
Another unexplained finding in the current investi¬
gation is

the lack of an antibody response to methylated

bovine serum albumin which is known to be antigenic under
the conditions of the experiment.

71
The results of immunization efforts with RITA are
somewhat difficult to interpret.

Sera from one of the

six rabbits injected with REA, when placed on an
Ouchterlony plate,

showed a double precipitating system

against RNA and REA core
in each of the lines).

(with a reaction of identity
However,

it is interesting that

pre-injection serum from this same rabbit showed a line
of precipitation with RITA core.

These results would

suggest the presence of antibodies against two distinct
constituents of both RITA and RITA core.
Immunization efforts with RITA core yielded in all
instances
REA-se.

(four rabbits) production of antibodies against
No antibodies against RITA or REA core were

detected.

Perhaps the most likely explanation for the

lack of an antibody response against RITA and RNA core
(in all of the above animals except one) is the use of too
short a period of immunization;
therefore,

be attempted.

further immunization will,

Another possibility may be an

inherently lower antigenicity of RNA and RITA core as
compared to denatured DNA.
Immunization with streptolysin S coupled by a
carbodiimide to rabbit serum albumin failed to induce an
antibody response against streptolysin S.

It would seem

worthwhile to further pursue this approach to immunization
with streptolysin 3 in the light of the success of
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Goodfriend _et al. with angiotensin and' bradykinin
Since the

(23).

shortcomings of this experiment are similar

to those discussed for the streptolysin S - MB3A experi¬
ment,

immunization of a large number of animals over a

period of months might be helpful.

It would also be of

interest to extract the carbodiimide induced precititate
in a manner similar to that used in the streptolysin
S - MB3A

studies to ascertain the presence of^strepto-

lysin 3 in the precipitate and its availability.
The experiments utilizing a Seitz filter as a
''carrier” and an

"adjuvant” yielded several unexpected

and interesting results.

In the following discussion

hyperlipemia will indicate a chemically determined
increase in serum lipids.

In five of seven experimental

animals the serum became opalescent post-implantation
and in one experimental and

one control animal

(the only

two animals thus studied) a transient but marked hyper¬
lipemia was observed,

characterized by an increase in

total cholesterol and cholesterol esters.
teristics

The charac¬

of this hyperlipemia may be contrasted to that

produced by other means.

Tsaltas reported that intra¬

venous injection of papain produced lipemia in adult
rabbits

(80).

Further studies indicated that the

lipemia was mostly due to a rise in the plasma glyceride
concentration without a significant alteration in the
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concentration of the other lipid fractions.

The lipemia

secondary to papain administration was accompanied by
moderate pulmonary edema and other stress phenomena.
Tsaltas and button postulated

that the stress reaction

precipitated by the papain injection could be considered
as the major cause of the lipemia (81).
It has also been reported that the injection of
pituitary gland extracts produced a lipemia in rabbits
which was very similar to the one produced by papain

(29).

Pituitary extracts were found to mobilize free fatty acid
from adipose tissue.

The latter was then resynthesized

into triglyceride which was directly responsible for a
lactescent hypertriglyceridemia.
The lipemia observed in the present study differs
from those discussed above in degree as well as in compo¬
sition.

The percent increase in total lipids in the

papain studies was about 15/5 as compared to a percent
Increase of 200^5 to 400/5 in the present study.

The

available

increase

chemistry determinations show a sharp

in total cholesterol

(over 100^5)

after the intraper-

itoneal implantation of the Seitz filter, whether it
x

was impregnated with streptolysin S (experimental rabbit)
or not

(control rabbit).

3y contrast,

total cholesterol

did not change significantly in the papain experiment.
No data are available on triglycerides' for our experiments.

*
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While cholesterol esters rose 60% to 135% in our experi¬
ments they fell 25% in the papain experiment.
In the same phase of the experiment
to implantation of the Seitz filter)

(with respect

as was the obser¬

vation of a transient hyperlipemia in the two rabbits
in which it was sought,
inhibitor

an increase in streptolysin S

(SSI) varying from 165% to 650O%> was also

noted in other rabbits

(330,

331 and 332).

This increase

in SSI may be related to the marked hyperlipemia dis¬
cussed above since previous studies

(6l) have demonstrated

that the SSI activity is associated with a phospholipoprotein complex.

It should be noted that two of the

three rabbits showing a significant rise of SSI had been
implanted with Seitz filters impregnated with a strep¬
tolysin 3 preparation which had not been previously
Millipore-filtered

(rabbits 331 and 332).

known that such preparations,

Since it is

though clear,

amounts of living streptococci,

contain large

it may be inferred that

these rabbits developed a streptococcal infection.
Unfortunately, we do not have lipid studies for these
rabbits.

It is pertinent to recall in this connection

that Todd

observed variable increases in 331

termed antistreptolysin S)

(which he

following prolonged courses

of intravenous injections of living group A streptococci
into rabbits,

ibout half of Todd's rabbits died during
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the course of the experiment with generalized strep¬
tococcal infections

(78).

Another interesting observation in the immunization
with streptolysin S bound to a Seitz filter was the line
of precipitation which formed between most early post¬
implantation sera and non-dialyzed streptolysin S.

This

precipitation could not be due to an antibody because it
occurred too soon after the implantation and because it
even occurred between sera from the control rabbit
(implanted intraperitoneally with a Seitz filter free of
streptolysin S)

and streptolysin 3.

Further studies will

be performed to elucidate the nature of this reaction.

SUMMARY

This thesis investigated the antigenicity of streptolysin S.

1.

Streptolysin 3 when injected into rabbits as a complex
with MBSA was not antigenic.

Precipitating antibodies

directed against MBSA were not produced.

However,

a

precipitating antibody was obtained which was directed
against RMA-se. (RITA-se was used in the preparation of
RITA core and RITA core in the preparation of streptolysin
S.)
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2.

Streptolysin S hemolytic activity could be recovered
in good yield from the precipitate which formed on
the addition of MBSA to streptolysin S.

3.

Post-injection serum from one of six rabbits injected
with RITA had antibodies against two distinct constit¬
uents of both RNA and RITA core.

Pre-injection serum

from this same rabbit gave a line of precipitation
with RITA core.
4.

All rabbits injected with RITA
against RITA - s e.
RITA core.)

core produced antibodies

(RNA-se was used in the preparation of

No antibodies against RITA core were pro¬

duced .
5.

Streptolysin S,

coupled by a carbodiimide to rabbit

serum albumin, was not antigenic when injected into
a rabbit.
6.

Streptolysin S when passed through a Seitz filter was
bound

to the filter and could be eluted from it by

solutions of high ionic strength.
7.

Streptolysin 3 when bound to a Seitz filter and implanted
intraperitoneally in rabbits was not antigenic.

In

some rabbits a marked increase in the streptolysin S
inhibitor titer was observed post-implantation.
one experimental animal and one control animal
only two animals thus studied)
hyperlipemia was observed.

In
(the

a transient but marked
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